Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Patents|February 22, 2014
CXCR2 modulators: a patent review (2009 - 2013)Michael P Dwyer, Younong YuCurrent Topics in Medicinal Chemistry|August 28, 2014
CXCR2 receptor antagonists: a medicinal chemistry perspectiveMichael P Dwyer, Younong YuBioorganic & Medicinal Chemistry|March 12, 2003
Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agentsYounong Yu, Sudhir K Singh, Angela Liu, et al.Journal of the American Chemical Society|May 16, 2018
Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position ConjugationYounong Yu, Li-Kang Zhang, Alexei V Buevich, et al.Bioorganic & Medicinal Chemistry Letters|February 10, 2009
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonistsPurakkattle Biju, Arthur G Taveras, Younong Yu, et al.Bioorganic & Medicinal Chemistry Letters|February 7, 2009
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonistsPurakkattle Biju, Arthur G Taveras, Michael P Dwyer, et al.ACS Medicinal Chemistry Letters|March 19, 2021
Synthesis of HDAC Inhibitor Libraries via Microscale WorkflowKevin D Dykstra, Eric Streckfuss, Min Liu, et al.Bioorganic & Medicinal Chemistry Letters|November 17, 2007
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonistsPurakkattle Biju, Arthur Taveras, Younong Yu, et al.Bioorganic & Medicinal Chemistry Letters|April 27, 2007
C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonistsJianhua Chao, Arthur G Taveras, Jianping Chao, et al.Pageof 3